FAN
TEVA icon

Financial Advisors Network’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Advisors Network’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-22
Closed -$759 – 413
2016
Q4 		$759 Buy
+22
New +$878 ﹤0.01% 493

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Financial Advisors Network's TEVA Position: Q1 2017 in Review

Financial Advisors Network sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 22 shares — an estimated $759 sold.

Financial Advisors Network first reported a position in TEVA in Q4 2016 and held it in 1 quarter. The position peaked at $759 in Q4 2016. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Financial Advisors Network reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Financial Advisors Network sold 22 Teva Pharmaceuticals shares in Q1 2017, an estimated $759.
  • Financial Advisors Network first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Financial Advisors Network's Teva Pharmaceuticals position peaked at $759 in Q4 2016.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Financial Advisors Network's 13F filing for Q1 2017, filed 17 May 2017.